Heron Announces September 2016 Quarterly Update on the High Grade Woodlawn Zinc-Copper Project
Oct 31, 2016 12:01 pm UTC| Business
Sydney, Australia, Oct. 31, 2016 -- Heron Resources Limited (TSX: HER; ASX: HRR) ("Heron" or the "Company") announces its quarterly activities for the three months ended September 30, 2016. Details of the Company's...
MyoKardia to Present at Two Upcoming Investor Conferences in November
Oct 31, 2016 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
MyoKardia to Present at Two Upcoming Investor Conferences in November
Oct 31, 2016 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
FibroGen Completes Enrollment in Roxadustat Phase 3 Studies in China
Oct 31, 2016 12:01 pm UTC| Business
SAN FRANCISCO, Oct. 31, 2016 -- FibroGen, Inc. (NASDAQ:FGEN), a research-based biopharmaceutical company, today reported completion of enrollment in its Phase 3 clinical trials in China for roxadustat (FG-4592) in...
FibroGen Completes Enrollment in Roxadustat Phase 3 Studies in China
Oct 31, 2016 12:01 pm UTC| Business
SAN FRANCISCO, Oct. 31, 2016 -- FibroGen, Inc. (NASDAQ:FGEN), a research-based biopharmaceutical company, today reported completion of enrollment in its Phase 3 clinical trials in China for roxadustat (FG-4592) in...
Vericel to Host Third-Quarter 2016 Earnings Webcast and Conference Call on November 7, 2016
Oct 31, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Oct. 31, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cellular therapies for the treatment of severe diseases and conditions, today announced the following...
Vericel to Host Third-Quarter 2016 Earnings Webcast and Conference Call on November 7, 2016
Oct 31, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Oct. 31, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cellular therapies for the treatment of severe diseases and conditions, today announced the following...
U.S. payrolls exceeded expectations significantly, while the unemployment rate dropps to 4.1%.